News
Kees Melief, CSO of ISA Pharmaceuticals, receives prestigious Coley Award
June 05, 2009
FOR IMMEDIATE RELEASE Scientific & Corporate Leaders in Immunology, Tumor Immunology to be Honored at Cancer Research Institute 23rd Annual Awards Dinner 2009 Grace and Coley Award Winners Announced
May 29,...
Read more
InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer
April 22, 2009
Bilthoven and Nijmegen (the Netherlands) - InteRNA Technologies B.V. and Radboud University Nijmegen Medical Centre have entered into a research agreement to develop microRNA (miRNA)-based therapeutics for p...
Read more
ISA Pharmaceuticals appoints Gerard Platenburg as CEO
April 21, 2009
ISA Pharmaceuticals B.V., the Dutch clinical stage biopharmaceutical company focusing on the development of therapeutic vaccines against cancer, today announced the further strengthening of its management te...
Read more
Syntarga Demonstrates In Vivo Proof of Concept for its Antibody-Drug Conjugate Technology
January 08, 2009
Syntarga B.V. announced today that it has demonstrated strong and broad In Vivo Proof of Concept for Antibody-Drug Conjugates (ADCs) incorporating the Company's payload technology. The proprietary platform c...
Read more
